| Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the US Preventive Services Task Force HJ De Koning, R Meza, SK Plevritis, K Ten Haaf, VN Munshi, J Jeon, ... Annals of internal medicine 160 (5), 311-320, 2014 | 518 | 2014 |
| Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications MA Shammas, P Neri, H Koley, RB Batchu, RC Bertheau, V Munshi, ... Blood 108 (8), 2804-2810, 2006 | 200 | 2006 |
| A clinically relevant SCID-hu in vivo model of human multiple myeloma P Tassone, P Neri, DR Carrasco, R Burger, VS Goldmacher, R Fram, ... Blood 106 (2), 713-716, 2005 | 163 | 2005 |
| Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials R Meza, K ten Haaf, CY Kong, A Erdogan, WC Black, MC Tammemagi, ... Cancer 120 (11), 1713-1724, 2014 | 84 | 2014 |
| Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling PM McMahon, R Meza, SK Plevritis, WC Black, CM Tammemagi, ... PloS one 9 (6), e99978, 2014 | 47 | 2014 |
| A SCID-hu in vivo model of human Waldenstrom macroglobulinemia P Tassone, P Neri, JL Kutok, O Tournilhac, DD Santos, E Hatjiharissi, ... Blood 106 (4), 1341-1345, 2005 | 46 | 2005 |
| The impact of overdiagnosis on the selection of efficient lung cancer screening strategies SS Han, K Ten Haaf, WD Hazelton, VN Munshi, J Jeon, SA Erdogan, ... International journal of cancer 140 (11), 2436-2443, 2017 | 43 | 2017 |
| Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease A Goehler, PM McMahon, HS Lumish, CC Wu, V Munshi, M Gilmore, ... Circulation 130 (8), 668-675, 2014 | 43 | 2014 |
| Cost-effectiveness evaluation of the 2021 US Preventive Services Task Force recommendation for lung cancer screening I Toumazis, K De Nijs, P Cao, M Bastani, V Munshi, K Ten Haaf, J Jeon, ... JAMA oncology 7 (12), 1833-1842, 2021 | 42 | 2021 |
| Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: a decision analysis KP Lowry, GS Gazelle, ME Gilmore, C Johanson, V Munshi, SE Choi, ... Cancer 121 (10), 1556-1562, 2015 | 41 | 2015 |
| Comparison of post-transplantation diabetes mellitus incidence and risk factors between kidney and liver transplantation patients VN Munshi, S Saghafian, CB Cook, KT Werner, HA Chakkera PloS one 15 (1), e0226873, 2020 | 30 | 2020 |
| Benefits and harms of computed tomography lung cancer screening programs for high-risk populations HJ de Koning, R Meza, SK Plevritis, K ten Haaf, VN Munshi, J Jeon, ... Rockv AHRQ 2, 2013 | 22 | 2013 |
| Incidence, risk factors, and trends for postheart transplantation diabetes mellitus VN Munshi, S Saghafian, CB Cook, DE Steidley, B Hardaway, ... The American Journal of Cardiology 125 (3), 436-440, 2020 | 20 | 2020 |
| Risk model–based lung cancer screening: a cost-effectiveness analysis I Toumazis, P Cao, K de Nijs, M Bastani, V Munshi, M Hemmati, ... Annals of internal medicine 176 (3), 320-332, 2023 | 17 | 2023 |
| Trends in state-level child mortality, maternal mortality, and fertility rates in India V Munshi, G Yamey, S Verguet Health Affairs 35 (10), 1759-1763, 2016 | 16 | 2016 |
| Importance of smoking cessation in a lung cancer screening program V Munshi, P McMahon Current surgery reports 1, 242-248, 2013 | 10 | 2013 |
| Cost-effectiveness analysis of the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of abnormal … VN Munshi, RB Perkins, S Sy, JJ Kim American Journal of Obstetrics and Gynecology 226 (2), 228. e1-228. e9, 2022 | 6 | 2022 |
| Use of imputation and decision modeling to improve diagnosis and management of patients at risk for new-onset diabetes after transplantation VN Munshi, S Saghafian, CB Cook, SV Aradhyula, HA Chakkera Annals of Transplantation 26, e928624-1, 2021 | 5 | 2021 |
| Benefits and Harms of Computed Tomography Lung Cancer Screening Programs for High-Risk Populations. AHRQ Publication No HJ de Koning, R Meza, SK Plevritis, K ten Haaf, VN Munshi, J Jeon 13-05196-EF, 2013 | 5 | 2013 |
| Cost-effectiveness analysis of the 2019 ASCCP Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursors VN MUNSHI, RB PERKINS, MS SY, TH Harvard American journal of obstetrics and gynecology 226 (2), 228. e1, 2022 | 3 | 2022 |
